409 678

Cited 54 times in

Xenon preconditioning: the role of prosurvival signaling, mitochondrial permeability transition and bioenergetics in rats.

DC Field Value Language
dc.contributor.author심연희-
dc.date.accessioned2015-04-24T16:57:54Z-
dc.date.available2015-04-24T16:57:54Z-
dc.date.issued2009-
dc.identifier.issn0003-2999-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/104503-
dc.description.abstractBACKGROUND: Similar to volatile anesthetics, the anesthetic noble gas xenon protects the heart from ischemia/reperfusion injury, but the mechanisms responsible for this phenomenon are not fully understood. We tested the hypothesis that xenon-induced cardioprotection is mediated by prosurvival signaling kinases that target mitochondria. METHODS: Male Wistar rats instrumented for hemodynamic measurements were subjected to a 30 min left anterior descending coronary artery occlusion and 2 h reperfusion. Rats were randomly assigned to receive 70% nitrogen/30% oxygen (control) or three 5-min cycles of 70% xenon/30% oxygen interspersed with the oxygen/nitrogen mixture administered for 5 min followed by a 15 min memory period. Myocardial infarct size was measured using triphenyltetrazolium staining. Additional hearts from control and xenon-pretreated rats were excised for Western blotting of Akt and glycogen synthase kinase 3 beta (GSK-3beta) phosphorylation and isolation of mitochondria. Mitochondrial oxygen consumption before and after hypoxia/reoxygenation and mitochondrial permeability transition pore opening were determined. RESULTS: Xenon significantly (P < 0.05) reduced myocardial infarct size compared with control (32 +/- 4 and 59% +/- 4% of the left ventricular area at risk; mean +/- sd) and enhanced phosphorylation of Akt and GSK-3beta. Xenon pretreatment preserved state 3 respiration of isolated mitochondria compared with the results obtained in the absence of the gas. The Ca(2+) concentration required to induce mitochondrial membrane depolarization was larger in the presence compared with the absence of xenon pretreatment (78 +/- 17 and 56 +/- 17 microM, respectively). The phosphoinositol-3-kinase-kinase inhibitor wortmannin blocked the effect of xenon on infarct size and respiration. CONCLUSIONS: These results indicate that xenon preconditioning reduces myocardial infarct size, phosphorylates Akt, and GSK-3beta, preserves mitochondrial function, and inhibits Ca(2+)-induced mitochondrial permeability transition pore opening. These data suggest that xenon-induced cardioprotection occurs because of activation of prosurvival signaling that targets mitochondria and renders them less vulnerable to ischemia-reperfusion injury-
dc.description.statementOfResponsibilityopen-
dc.format.extent858~866-
dc.relation.isPartOfANESTHESIA AND ANALGESIA-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAnesthetics, Inhalation/pharmacology*-
dc.subject.MESHAnimals-
dc.subject.MESHBlood Pressure/drug effects-
dc.subject.MESHBlotting, Western-
dc.subject.MESHCalcium/pharmacology-
dc.subject.MESHCardiotonic Agents*-
dc.subject.MESHEnergy Metabolism/drug effects*-
dc.subject.MESHGlycogen Synthase Kinase 3/metabolism-
dc.subject.MESHGlycogen Synthase Kinase 3 beta-
dc.subject.MESHHeart Rate/drug effects-
dc.subject.MESHIschemic Preconditioning, Myocardial*-
dc.subject.MESHMale-
dc.subject.MESHMitochondria, Heart/drug effects*-
dc.subject.MESHMitochondria, Heart/pathology-
dc.subject.MESHMyocardial Infarction/pathology-
dc.subject.MESHMyocardial Infarction/prevention & control-
dc.subject.MESHMyocardial Reperfusion Injury/pathology-
dc.subject.MESHMyocardial Reperfusion Injury/prevention & control*-
dc.subject.MESHOxygen Consumption/drug effects-
dc.subject.MESHPermeability/drug effects-
dc.subject.MESHPhosphorylation-
dc.subject.MESHProto-Oncogene Proteins c-akt/metabolism-
dc.subject.MESHRats-
dc.subject.MESHRats, Wistar-
dc.subject.MESHXenon/pharmacology*-
dc.titleXenon preconditioning: the role of prosurvival signaling, mitochondrial permeability transition and bioenergetics in rats.-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Anesthesiology (마취통증의학)-
dc.contributor.googleauthorYasushi Mio-
dc.contributor.googleauthorYon Hee shim-
dc.contributor.googleauthorEbony Richards-
dc.contributor.googleauthorZeljko J. Bosnjak-
dc.contributor.googleauthorPaul S. Pagel-
dc.contributor.googleauthorMartin Bienengraeber-
dc.identifier.doi10.1213/ane.0b013e318192a520-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA02196-
dc.relation.journalcodeJ00144-
dc.identifier.eissn1526-7598-
dc.identifier.pmid19224794-
dc.contributor.alternativeNameShim, Yon Hee-
dc.contributor.affiliatedAuthorShim, Yon Hee-
dc.citation.volume108-
dc.citation.number3-
dc.citation.startPage858-
dc.citation.endPage866-
dc.identifier.bibliographicCitationANESTHESIA AND ANALGESIA, Vol.108(3) : 858-866, 2009-
dc.identifier.rimsid54169-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Anesthesiology and Pain Medicine (마취통증의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.